Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity? - 16/06/21
pages | 2 |
Iconographies | 0 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Sarcopenia was initially defined as loss of muscle mass, strength and function related to aging. This phenomenon is a multifactorial process. The evaluation of the geriatric population in which sarcopenia has extensively been studied opens the field for other chronic diseases. Cirrhosis is one of them and the term “sarcopenia” is now also used in this pathological situation. It must be emphasized that the pathophysiology of sarcopenia in cirrhosis is likely different from the pathogenesis in geriatric patients. Furthermore, cirrhosis has heterogeneous causes. Therefore, we need a better understanding of the changes in muscle physiology specifically in chronic liver diseases as well as easy, accurate, reproducible and validated tools, taking into consideration etiology specific aspects to identify sarcopenia in every cirrhotic patient.
Le texte complet de cet article est disponible en PDF.Abbreviation : MAFLD
Keywords : Frailty, Sarcopenia, Muscle, Cirrhosis, Myosteatosis, MAFLD
Plan
Vol 45 - N° 4
Article 101721- juillet 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?